West Pharmaceutical Services Inc Cash Flow Conversion Efficiency
West Pharmaceutical Services Inc cash flow conversion efficiency. Based on the latest financial reports, West Pharmaceutical Services Inc (WST) has a cash flow conversion efficiency ratio of 0.030x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($89.90 Million) by net assets ($2.99 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of West Pharmaceutical Services Inc (1989–2025)
Cash flow conversion efficiency of West Pharmaceutical Services Inc from 1989 to 2025. This chart illustrates how West Pharmaceutical Services Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View West Pharmaceutical Services Inc share price for real-time trading data and today's change.
West Pharmaceutical Services Inc Cash Flow Conversion Ratio Explained
West Pharmaceutical Services Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
West Pharmaceutical Services Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of West Pharmaceutical Services Inc ranked by their cash flow conversion efficiency. Also see West Pharmaceutical Services Inc stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Alfa Laval AB
ST:ALFA
|
0.053x |
|
Cathay Financial Holding Co Ltd Pref A
TW:2882A
|
-0.066x |
|
Grasim Industries Limited
NSE:GRASIM
|
-0.049x |
|
ABN AMRO BK.UNSP.ADR/1
F:AB2A
|
N/A |
|
Shanxi Xinghuacun Fen Wine Factory Co Ltd
SHG:600809
|
0.080x |
|
GigaDevice Semiconductor(Beiji
SHG:603986
|
0.035x |
|
First Citizens BancShares, Inc.
NASDAQ:FCNCA
|
0.048x |
|
Omnicom Group Inc
NYSE:OMC
|
-0.037x |
Annual Cash Flow Conversion Efficiency for West Pharmaceutical Services Inc (1989–2025)
The table below shows the annual cash flow conversion efficiency of West Pharmaceutical Services Inc from 1989 to 2025. Review West Pharmaceutical Services Inc (WST) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $3.18 Billion | $754.80 Million | 0.238x | -2.44% |
| 2024-12-31 | $2.68 Billion | $653.40 Million | 0.244x | -9.62% |
| 2023-12-31 | $2.88 Billion | $776.50 Million | 0.270x | -0.05% |
| 2022-12-31 | $2.68 Billion | $724.00 Million | 0.270x | +7.83% |
| 2021-12-31 | $2.34 Billion | $584.00 Million | 0.250x | -1.85% |
| 2020-12-31 | $1.85 Billion | $472.50 Million | 0.255x | +9.16% |
| 2019-12-31 | $1.57 Billion | $367.20 Million | 0.233x | -18.33% |
| 2018-12-31 | $1.01 Billion | $288.60 Million | 0.286x | +80.81% |
| 2017-12-31 | $1.67 Billion | $263.30 Million | 0.158x | -19.49% |
| 2016-12-31 | $1.12 Billion | $219.40 Million | 0.196x | -5.36% |
| 2015-12-31 | $1.02 Billion | $212.40 Million | 0.207x | +8.67% |
| 2014-12-31 | $958.10 Million | $182.90 Million | 0.191x | -21.53% |
| 2013-12-31 | $906.40 Million | $220.50 Million | 0.243x | -5.38% |
| 2012-12-31 | $728.90 Million | $187.40 Million | 0.257x | +28.83% |
| 2011-12-31 | $654.90 Million | $130.70 Million | 0.200x | -9.71% |
| 2010-12-31 | $625.70 Million | $138.30 Million | 0.221x | -7.04% |
| 2009-12-31 | $579.10 Million | $137.70 Million | 0.238x | -14.20% |
| 2008-12-31 | $487.10 Million | $135.00 Million | 0.277x | +5.30% |
| 2007-12-31 | $490.90 Million | $129.20 Million | 0.263x | -23.26% |
| 2006-12-31 | $419.30 Million | $143.80 Million | 0.343x | +33.86% |
| 2005-12-31 | $334.10 Million | $85.60 Million | 0.256x | +15.50% |
| 2004-12-31 | $310.60 Million | $68.90 Million | 0.222x | -17.42% |
| 2003-12-31 | $257.60 Million | $69.20 Million | 0.269x | +4.01% |
| 2002-12-31 | $208.70 Million | $53.90 Million | 0.258x | +39.64% |
| 2001-12-31 | $176.80 Million | $32.70 Million | 0.185x | -18.52% |
| 2000-12-31 | $214.10 Million | $48.60 Million | 0.227x | -24.12% |
| 1999-12-31 | $232.00 Million | $69.40 Million | 0.299x | -3.85% |
| 1998-12-31 | $228.20 Million | $71.00 Million | 0.311x | +27.81% |
| 1997-12-31 | $278.10 Million | $67.70 Million | 0.243x | -3.12% |
| 1996-12-31 | $252.30 Million | $63.40 Million | 0.251x | +38.62% |
| 1995-12-31 | $254.30 Million | $46.10 Million | 0.181x | -16.57% |
| 1994-12-31 | $229.20 Million | $49.80 Million | 0.217x | +12.31% |
| 1993-12-31 | $199.00 Million | $38.50 Million | 0.193x | +1.68% |
| 1992-12-31 | $178.70 Million | $34.00 Million | 0.190x | -30.97% |
| 1991-12-31 | $161.10 Million | $44.40 Million | 0.276x | +43.77% |
| 1990-12-31 | $187.80 Million | $36.00 Million | 0.192x | -15.64% |
| 1989-12-31 | $188.80 Million | $42.90 Million | 0.227x | -- |
About West Pharmaceutical Services Inc
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; sy… Read more